Found: 6
Select item for more details and to access through your institution.
Mechanism-Based Pharmacokinetic/Pharmacodynamic Model for THIOMAB™ Drug Conjugates.
- Published in:
- Pharmaceutical Research, 2015, v. 32, n. 6, p. 1884, doi. 10.1007/s11095-014-1582-1
- By:
- Publication type:
- Article
Development and Translational Application of an Integrated, Mechanistic Model of Antibody-Drug Conjugate Pharmacokinetics.
- Published in:
- AAPS Journal, 2017, v. 19, n. 1, p. 130, doi. 10.1208/s12248-016-9993-z
- By:
- Publication type:
- Article
Differential Effects of Predosing on Tumor and Tissue Uptake of an <sup>111</sup>In-Labeled Anti-TENB2 Antibody–Drug Conjugate.
- Published in:
- Journal of Nuclear Medicine, 2012, v. 53, n. 9, p. 1454, doi. 10.2967/jnumed.112.103168
- By:
- Publication type:
- Article
An integrated approach to identify normal tissue expression of targets for antibody-drug conjugates: case study of TENB2.
- Published in:
- British Journal of Pharmacology, 2013, v. 168, n. 2, p. 445, doi. 10.1111/j.1476-5381.2012.02138.x
- By:
- Publication type:
- Article
Tutorial on Monoclonal Antibody Pharmacokinetics and Its Considerations in Early Development.
- Published in:
- CTS: Clinical & Translational Science, 2018, v. 11, n. 6, p. 540, doi. 10.1111/cts.12567
- By:
- Publication type:
- Article
Pharmacokinetic Considerations for Antibody Drug Conjugates.
- Published in:
- Pharmaceutical Research, 2012, v. 29, n. 9, p. 2354, doi. 10.1007/s11095-012-0800-y
- By:
- Publication type:
- Article